PMC:7242013 / 12473-12622 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"352","span":{"begin":84,"end":88},"obj":"Gene"},{"id":"377","span":{"begin":37,"end":48},"obj":"Disease"}],"attributes":[{"id":"A352","pred":"tao:has_database_id","subj":"352","obj":"Gene:3569"},{"id":"A377","pred":"tao:has_database_id","subj":"377","obj":"MESH:D006509"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ID‐19. APASL recommends prophylactic hepatitis B therapy for those planned for anti‐IL‐6 or other immunosuppressive therapy. Initiating prophylactic "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T156","span":{"begin":37,"end":48},"obj":"Disease"},{"id":"T157","span":{"begin":37,"end":46},"obj":"Disease"}],"attributes":[{"id":"A156","pred":"mondo_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/MONDO_0005344"},{"id":"A157","pred":"mondo_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"}],"text":"ID‐19. APASL recommends prophylactic hepatitis B therapy for those planned for anti‐IL‐6 or other immunosuppressive therapy. Initiating prophylactic "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T101","span":{"begin":47,"end":48},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"ID‐19. APASL recommends prophylactic hepatitis B therapy for those planned for anti‐IL‐6 or other immunosuppressive therapy. Initiating prophylactic "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T47","span":{"begin":84,"end":86},"obj":"Chemical"}],"attributes":[{"id":"A47","pred":"chebi_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A48","pred":"chebi_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"ID‐19. APASL recommends prophylactic hepatitis B therapy for those planned for anti‐IL‐6 or other immunosuppressive therapy. Initiating prophylactic "}

{"project":"LitCovid-sentences","denotations":[{"id":"T139","span":{"begin":7,"end":124},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ID‐19. APASL recommends prophylactic hepatitis B therapy for those planned for anti‐IL‐6 or other immunosuppressive therapy. Initiating prophylactic "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T31","span":{"begin":37,"end":46},"obj":"Phenotype"}],"attributes":[{"id":"A31","pred":"hp_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"ID‐19. APASL recommends prophylactic hepatitis B therapy for those planned for anti‐IL‐6 or other immunosuppressive therapy. Initiating prophylactic "}